OHA: Managed Care Laws - Cancer

As new treatment options become available, it is important to make sure laws are put into place to extend coverage for patients who undergo clinical trials.  Although not everyone will have the same health plan coverage, it is important to investigate what is available to you.

Effective October 1, 2001, the Connecticut General Assembly passed an Act (PA 01-171) that requires managed care health plans to begin covering certain aspects of clinical cancer trials for the treatment of cancer and Phase III Trials for the prevention of cancer.  A cancer prevention trial must be a Phase III Trial, involve therapeutic intervention, and be conducted at several institutions.

Effective on January 1, 2012, Public Act 11-172 expands coverage for routine care costs associated with clinical trials for patients with the following disabling, progressive or life threatening conditions: Cancer, Multiple Sclerosis, Parkinson's disease, Amyotrophic Lateral Aclerosis (ALS), Acquired Immunodeficiency Syndrome (AIDS) and Muscular Dystrophy.  The law requires coverage for routine care costs for trials, including those that are not preventive.  It also requires coverage of routine care costs for clinical trials approved by Medicare.

For more information…

If you have questions, contact us via email or call toll-free at 1 (866) HMO-4446.



Content Last Modified on 7/20/2011 10:33:07 AM